LinkOPH

VIENNA — Results of DRCR.net Protocol T may signal a paradigm shift in the treatment of diabetic macular edema, but are scarcely applicable to the European clinical context, where ranibizumab is marketed and used at a higher 0.5 mg concentration, a specialist told colleagues here.“Protocol T showed superior efficacy of aflibercept, particularly in the group of patients with more severe disease. However, the 0.3 mg ranibizumab concentration used in the study is the one registered for the US market, which is nearly half the concentration we use in Europe,” Francesco (Read more...)

Arnold & Porter LLP will host the first of a three-part webcast series, “Healthcare Joint Ventures and Transactions: A Response to the Changing Healthcare Payment and Delivery Landscape,” on June 16. Nicole Liffrig Molife and J. Matthew Owens will kick off the series at 12 p.m. EST with part one: “Getting Your House in Order: Key Compliance and Corporate Issues that Diminish Value or Kill the Deal.” The counselors will focus on corporate and compliance issues that may jeopardize a deal or diminish its value, while also concentrating on how (Read more...)

VIENNA — DMEK surgery has been widely adopted in Europe with rewarding results, according to one surgeon. “In Europe, about 40% of the grafts are performed for endothelial dysfunction, mainly for Fuchs dystrophy,” Friedrich Kruse, MD, said at the meeting of the European Society of Ophthalmology.

Read more →